Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas

Hagelstein, Ilona; Lutz, Martina S.; Schmidt, Moritz; Heitmann, Jonas S.; Malenke, Elke; Zhou, Yanjun; Clar, Kim L.; Kopp, Hans-Georg; Jung, Gundram; Salih, Helmut R.; Maerklin, Melanie; Hinterleitner, Clemens

dc.contributor.author	Hagelstein, Ilona
dc.contributor.author	Lutz, Martina
dc.contributor.author	Schmidt, Moritz
dc.contributor.author	Heitmann, Jonas S.
dc.contributor.author	Malenke, Elke
dc.contributor.author	Zhou, Yanjun
dc.contributor.author	Clar, Kim L.
dc.contributor.author	Kopp, Hans-Georg
dc.contributor.author	Jung, Gundram
dc.contributor.author	Hinterleitner, Clemens
dc.contributor.author	Salih, Helmut R.
dc.contributor.author	Märklin, Melanie
dc.date.accessioned	2021-09-07T07:24:02Z
dc.date.available	2021-09-07T07:24:02Z
dc.date.issued	2021
dc.identifier.issn	1664-3224
dc.identifier.uri	http://hdl.handle.net/10900/118639
dc.language.iso	en	de_DE
dc.publisher	Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fimmu.2021.653081	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas	de_DE
dc.type	Article	de_DE
utue.quellen.id	20210512015105_00081
utue.personen.roh	Hagelstein, Ilona
utue.personen.roh	Lutz, Martina S.
utue.personen.roh	Schmidt, Moritz
utue.personen.roh	Heitmann, Jonas S.
utue.personen.roh	Malenke, Elke
utue.personen.roh	Zhou, Yanjun
utue.personen.roh	Clar, Kim L.
utue.personen.roh	Kopp, Hans-Georg
utue.personen.roh	Jung, Gundram
utue.personen.roh	Salih, Helmut R.
utue.personen.roh	Maerklin, Melanie
utue.personen.roh	Hinterleitner, Clemens
dcterms.isPartOf.ZSTitelID	Frontiers in Immunology	de_DE
dcterms.isPartOf.ZS-Issue	Article 653081	de_DE
dcterms.isPartOf.ZS-Volume	12	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE
utue.fakultaet	07 Mathematisch-Naturwissenschaftliche Fakultät	de_DE